mRNA-1189 — catalyst calendar
Upcoming
| Date | Event | Company | Drug | Official source & verification |
|---|---|---|---|---|
| 2026-10-05 in 2mo
ESTIMATED |
READOUT
A Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 3
Phase 1/2 · Epstein-Barr Virus Infection |
ModernaTX, Inc. | mRNA-1189 |
ClinicalTrials.gov ↗
✓ Source-checked 2026-08-06
Sponsor-projected date — can change
|